Abstract Recurrent mutations in TP53. RAS pathway and JAK2 genes were shown to be highly prognostic of allogeneic hematopoietic cell transplant (alloHCT) outcomes in myelodysplastic syndromes (MDS). However. a significant proportion of MDS patients has no such mutations. https://www.spidertattooz.com/